181 related articles for article (PubMed ID: 24285218)
1. Suicide gene approach using a dual-expression lentiviral vector to enhance the safety of ex vivo gene therapy for bone repair.
Alaee F; Sugiyama O; Virk MS; Tang H; Drissi H; Lichtler AC; Lieberman JR
Gene Ther; 2014 Feb; 21(2):139-47. PubMed ID: 24285218
[TBL] [Abstract][Full Text] [Related]
2. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
4. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T
Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach.
Bougioukli S; Alluri R; Pannell W; Sugiyama O; Vega A; Tang A; Skorka T; Park SH; Oakes D; Lieberman JR
Bone; 2019 Nov; 128():115032. PubMed ID: 31398502
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells.
Lim TT; Geisen C; Hesse M; Fleischmann BK; Zimmermann K; Pfeifer A
PLoS One; 2013; 8(7):e70543. PubMed ID: 23936225
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells.
Hossain JA; Ystaas LR; Mrdalj J; Välk K; Riecken K; Fehse B; Bjerkvig R; Grønli J; Miletic H
J Gene Med; 2016 Sep; 18(9):234-43. PubMed ID: 27490042
[TBL] [Abstract][Full Text] [Related]
8. Using HSV-TK/GCV suicide gene therapy to inhibit lens epithelial cell proliferation for treatment of posterior capsular opacification.
Jiang YX; Lu Y; Liu TJ; Yang J; Chen Y; Fang YW
Mol Vis; 2011 Jan; 17():291-9. PubMed ID: 21283526
[TBL] [Abstract][Full Text] [Related]
9. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
10. Cancer Suicide Gene Therapy with TK.007.
Hossain JA; Riecken K; Miletic H; Fehse B
Methods Mol Biol; 2019; 1895():11-26. PubMed ID: 30539526
[TBL] [Abstract][Full Text] [Related]
11. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
[TBL] [Abstract][Full Text] [Related]
13. Regulated ex vivo regional gene therapy for bone repair using an inducible caspase-9 suicide gene system.
Bougioukli S; Vakhshori V; Ortega B; Sugiyama O; Lieberman J
Gene Ther; 2019 Jun; 26(6):230-239. PubMed ID: 30962534
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of the inhibiting effect of the lentiviral vector mediated herpes simplex virus-thymidine kinase/ganciclovir on GVHD].
Xu KL; Zhu F; Du B; Gao F; Cheng H; Pan XY
Zhonghua Xue Ye Xue Za Zhi; 2007 May; 28(5):303-7. PubMed ID: 17877157
[TBL] [Abstract][Full Text] [Related]
15. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
16. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
[TBL] [Abstract][Full Text] [Related]
17. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
18. Antibody-directed double suicide gene therapy targeting of MUC1- positive leukemia cells in vitro and in vivo.
Dong XY; Wang WQ; Zhao Y; Li XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Pan GJ; Liu JJ
Curr Gene Ther; 2013 Oct; 13(5):346-57. PubMed ID: 24060312
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of graft-versus-host disease by lentiviral-mediated expression of herpes simplex virus-thymidine kinase and ganciclovir treatment.
Xu K; Zhu F; Du B; Gao F; Cheng H; Pan X
Transplant Proc; 2008 Oct; 40(8):2665-9. PubMed ID: 18929831
[TBL] [Abstract][Full Text] [Related]
20. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models.
Feeley BT; Conduah AH; Sugiyama O; Krenek L; Chen IS; Lieberman JR
J Orthop Res; 2006 Aug; 24(8):1709-21. PubMed ID: 16788987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]